Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04849455 · ClinicalTrials.gov registry record · Phase 4

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

A Phase 4 study of Anesthesia and Acute Pain, sponsored by University of California, San Diego.

Recruiting
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT04849455: Recruiting Phase 4 study of Anesthesia and Acute Pain, sponsored by University of California, San Diego.

NCT04849455 is a Phase 4 study of Anesthesia and Acute Pain that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 70 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04849455, a Phase 4 study of Anesthesia and Acute Pain, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

Primary Outcome

Morphine Milligram Equivalents

Interventions

  • DRUG 0.2% ropivacaine local anesthetic continuous erector spinae plane block
  • DRUG 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block
  • DRUG Spinal Morphine

Study Locations (1)

California

  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2021-05-24
Est. Completion 2023-05-01
Phase Phase 4
University of California, San Diego

775 total trials

What NCT04849455 shows while recruiting

NCT04849455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Anesthesia appearing as the primary indexed condition, and to 3 interventions - of which 0.2% ropivacaine local anesthetic continuous erector spinae plane block is the first listed.

NCT04849455 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04849455 about?

NCT04849455 is a clinical study titled "Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection". To determine whether the addition of erector spinae plane (ESP) catheters to existing multimodal analgesic regimen with intrathecal morphine provides superior postoperative analgesia in patients undergoing hepatic resection compared with patients not receiving ESP catheters.

What is the current status of trial NCT04849455?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2021-05-24. Estimated completion is 2023-05-01.

What conditions does trial NCT04849455 study?

This clinical trial studies the following conditions: Anesthesia, Acute Pain, Anesthesia, Local, Hepatic Resection.

What interventions are being tested in trial NCT04849455?

The interventions under investigation include: 0.2% ropivacaine local anesthetic continuous erector spinae plane block (DRUG), 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block (DRUG), Spinal Morphine (DRUG).

Who is sponsoring clinical trial NCT04849455?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04849455 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04849455's enrollment target sits among peer trials

70 22nd of 57 higher than 36 of 57 other Anesthesia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04849455, the US trial registry maintained by the National Library of Medicine. NCT04849455 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.